X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Daily MedNews - 03/Jul 12:07

FDA Warns of 48 Illnesses, One Death Linked to Diamond Shruumz Edibles

WEDNESDAY, July 3, 2024 -- The U.S. Food and Drug Administration said Tuesday it is now investigating nearly 50 illnesses and one death that may be linked to eating Diamond Shruumz edibles. Of the 48 people in 24 states who said they got sick after...

Articles similaires

Sorry! Image not available at this time

All Diamond Shruumz Edibles Recalled Over High Levels of Mushroom Toxin in Products

drugs.com - 01/Jul 12:07

MONDAY, July 1, 2024 -- All Diamond Shruumz edibles have been recalled after the company found high levels of a mushroom toxin in them that may have...

Sorry! Image not available at this time

FDA Bans Food Additive Found in Sports Drinks, Sodas

drugs.com - 03/Jul 12:07

WEDNESDAY, July 3, 2024 -- A regulation allowing the use of brominated vegetable oil in food was revoked Tuesday by the U.S. Food and Drug...

U.S. abortion restrictions have unwanted knock-on effects: studies

rawstory.com - 26/Jun 15:49

Restrictions or outright bans on abortion implemented in some U.S. states can have unexpected consequences like reduced access to contraceptives and...

Sorry! Image not available at this time

FDA Approves New Drug to Treat Alzheimer's, Kisunla

drugs.com - 02/Jul 19:07

TUESDAY, July 2, 2024 -- A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials,...

Sorry! Image not available at this time

Newsdeck: US FDA approves Lilly’s Alzheimer’s drug

daily maverick - 02/Jul 19:01

July 2 - The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's LLY.N donanemab for patients with early Alzheimer's,...

Sorry! Image not available at this time

FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease

drugs.com - 02/Jul 19:07

INDIANAPOLIS, July 2, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Kisunla™ (donanemab-azbt, 350 mg/20 mL...

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

news.medical.net - 25/Jun 14:52

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell...

Sorry! Image not available at this time

FDA Warns Top National Bakery to Stop Listing Allergens in Products When They Aren't There

drugs.com - 28/Jun 11:49

FRIDAY, June 28, 2024 -- The U.S. Food and Drug Administration has sent a warning letter to one of America's biggest bakeries, asking the company to...

Sorry! Image not available at this time

FDA Approves Ahzantive (aflibercept-mrbb), a Biosimilar to Eylea

drugs.com - 01/Jul 23:07

Planegg-Martinsried, Germany July 1, 2024 – Formycon AG (FSE: FYB, “Formycon”) and its licensing partner Klinge Biopharma GmbH...

Sorry! Image not available at this time

FDA Approves Capvaxive Pneumococcal 21-Valent Conjugate Vaccine

drugs.com - 21/Jun 22:51

FRIDAY, June 21, 2024 -- The U.S. Food and Drug Administration has approved the Capvaxive pneumococcal 21-valent conjugate vaccine for the prevention...